AKTHELIA
Akthelia is an emerging pharmaceutical company focused on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The ever-increasing resistance to currently marketed antibiotics has led to a clear need for novel anti-infective agents that are active against drug resistant bacteria, opportunistic infections and acute infections of unknown causes. Akthelia has a diverse pipeline of products under development, targeting microbial ... infections. The current focus is on lung and gastrointestinal infections. In close collaboration with scientists at the Karolinska Institute in Stockholm and University of Iceland, evidence of new active ingredients and modes of action is being generated. The ensuing research is feeding the product pipeline and generating new product opportunities for further development.
AKTHELIA
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2001-12-01
Address:
Reykjavík, Gullbringusysla, Iceland
Country:
Iceland
Website Url:
http://www.akthelia.is
Total Employee:
1+
Status:
Active
Contact:
(354)510-1800
Email Addresses:
[email protected]
Total Funding:
64 M ISK
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Nginx Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Arakis Limited
Arakis Limited focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy.
Avicenna Oncology
Avicenna Oncology is a start-up dedicated to the Discovery & Development of new generation of cytotoxic agents.
Bionity
Drug discovery and development of novel anticancer drugs.
Everna
Everna is a biotech company developing novel therapeutics.
G.ST Antivirals
G.ST Antivirals focuses on the development of antiviral drugs.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Polypharmakos
Polypharmakos's mission is to discover and develop new antimicrobials from plants, fungi.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
SR Pharma
It was founded in 1992 and develops novel medicine.
Vaxxilon
Vaxxilon AG is focused on the discovery and development of innovative synthetic carbohydrate vaccines.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Technology Development Fund
Technology Development Fund investment in Grant - Akthelia
Technology Development Fund
Technology Development Fund investment in Grant - Akthelia
Technology Development Fund
Technology Development Fund investment in Grant - Akthelia
Official Site Inspections
http://www.akthelia.is
- Host name: cpanel-01.premis.is
- IP address: 178.248.20.101
- Location: Kopavogur Iceland
- Latitude: 64.1107
- Longitude: -21.9079
- Timezone: Atlantic/Reykjavik
- Postal: 200
